de Steenhuijsen Piters, Wouter A A
Huijskens, Elisabeth G W
Wyllie, Anne L
Biesbroek, Giske
van den Bergh, Menno R
Veenhoven, Reinier H
Wang, Xinhui
TrzciĆski, Krzysztof
Bonten, Marc J
Rossen, John W A
Sanders, Elisabeth A M
Bogaert, Debby
Article History
Received: 25 November 2014
Revised: 3 March 2015
Accepted: 4 May 2015
First Online: 7 July 2015
Competing interests
: EAMS declares to have received unrestricted research support from Pfizer, grant support for vaccine studies from Pfizer and GlaxoSmithKline and fees paid to the institution for advisory boards or participation in independent data monitoring committees for Pfizer and GSK. RHV reported receiving grant support from GlaxoSmithKline and Wyeth/Pfizer for vaccine studies and consulting fees from GlaxoSmithKline. KT received grant support and consulting fees from Pfizer. DB received consulting fees from Pfizer. These grants and fees were not received for the research described in this paper. The remaining authors declare no conflict of interest.